36. Epidermolysis bullosa Clinical trials / Disease details


Clinical trials : 163 Drugs : 185 - (DrugBank : 46) / Drug target genes : 50 - Drug target pathways : 125

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00311766
(ClinicalTrials.gov)
February 20064/4/2006A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis BullosaA Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis BullosaEpidermolysis BullosaDrug: Thymosin Beta 4;Drug: PlaceboRegeneRx Biopharmaceuticals, Inc.NULLTerminated2 YearsN/AAll30Phase 2United States